Invitae: Exponential Growth In Genetic Testing

I think the biggest innovations of the 21st century will be the intersection of biology and technology. A new era is beginning. - Steve Jobs

Invitae (NVTA) is a market leader in genetic testing, the company is growing at full speed and it has enormous room for further growth in the years ahead. Investments in R&D and marketing are significantly hurting profitability, and this is a major risk factor for investors in Invitae. That being acknowledged, the stock could offer massive returns from current levels if management executes well in the years ahead.

Exponential Growth Opportunities

Invitae delivers affordable genetic testing solutions with a focus on areas such as cancer, heart disease, fertility, and pregnancy, among others. Genetic testing is a relatively new area in medicine, but it has already proven to have enormous benefits, and we are only seeing the tip of the iceberg in terms of the possibilities that this technology has to offer.

It is not unreasonable to say that over the long term declining testing costs should allow for a large share of the global population to access the benefits of genetic testing, and Invitae should be both one of the major driving forces in this revolution and a leading beneficiary from it.

From the company's annual report:

Combining genetic testing services that support patient care throughout life's journey - from inherited disease diagnosis, to family planning, to proactive health screening - with a unique, rapidly expanding network of patients, healthcare providers, biopharma and advocacy partners, Invitae is capturing the broad potential of genetics and helping to expand its use across the healthcare continuum. Through the custom design and application of automation, robotics and bioinformatics software solutions tailored to the complexity of sample processing and complex variant interpretation, Invitae can apply its world-class clinical expertise to medical interpretation at scale, simplifying the process of obtaining and utilizing affordable, high-quality genetic information to inform critical healthcare decisions while making genetic testing available for billions of people. By pioneering new ways of sharing and understanding genetic information, Invitae is transforming the field of genetics from one-dimensional testing to complex information management.

1 2 3 4
View single page >> |

Disclosure: I am/we are long NVTA.

Disclaimer: I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.